Retail was Cresco Labs’s largest segment in fiscal 2025, bringing in $433.08M of $655.85M (66%).
| Segment | FY 2024 | FY 2025 |
|---|---|---|
| Retail | $471.75M | $433.08M |
| Wholesale | $417.94M | $387.80M |
| Intersegment Eliminations | -$165.35M | -$165.03M |
| Total | $724.34M | $655.85M |
Cresco Labs brought in $655.85M from its three segments in fiscal 2025, the year ended December 31, 2025. That was down 9.5% from $724.34M in fiscal 2024. Retail was the largest at $433.08M (66.0%), ahead of Wholesale at $387.80M (59.1%).
Compared with fiscal 2024, Wholesale fell 7.2% to $387.80M and Retail fell 8.2% to $433.08M.
The total is net of Intersegment Eliminations, which took $165.03M off revenue in fiscal 2025.
Other Entities Including Cresco Labs Llc was Cresco Labs’s largest revenue line in fiscal 2020, bringing in $386.26M of $475.97M (81%).
| Consolidated Entities | FY 2020 |
|---|---|
| Other Entities Including Cresco Labs Llc | $386.26M |
| Medmar Inc Rockford | $38.42M |
| Slo Cultivation Inc | $19.77M |
| Tsc Cresco, Llc | $16.87M |
| Cresco Labs Ohio, Llc | $14.65M |
| Total | $475.97M |
Cresco Labs brought in $475.97M from its five revenue lines in fiscal 2020, the year ended December 31, 2020. Other Entities Including Cresco Labs Llc was the largest at $386.26M (81.2%), ahead of Medmar Inc Rockford at $38.42M (8.1%) and Slo Cultivation Inc at $19.77M (4.2%). The other two revenue lines brought in $31.52M combined.
Dispensary was Cresco Labs’s largest product and service line in fiscal 2023, bringing in $464.52M of $770.89M (60%).
| Product and Service | FY 2023 |
|---|---|
| Dispensary | $464.52M |
| Wholesale | $306.36M |
| Total | $770.89M |
Cresco Labs brought in $770.89M from its two product and service lines in fiscal 2023, the year ended December 31, 2023. Dispensary was the largest at $464.52M (60.3%), ahead of Wholesale at $306.36M (39.7%).
Cresco Labs (CRLBF) reports its revenue by segment, by consolidated entities and by product and service. In fiscal 2025, Retail was its largest segment, bringing in $433.08M (66.0% of the total), followed by Wholesale at $387.80M (59.1%).
Retail was Cresco Labs' largest segment in fiscal 2025, bringing in $433.08M, or 66.0% of the $655.85M total across its three segments.
Other Entities Including Cresco Labs Llc was Cresco Labs' largest revenue line in fiscal 2020, bringing in $386.26M, or 81.2% of the $475.97M total across its five revenue lines.
Dispensary was Cresco Labs' largest product and service line in fiscal 2023, bringing in $464.52M, or 60.3% of the $770.89M total across its two product and service lines.
Every figure comes from Cresco Labs' annual financial filings, as reported. Each line keeps the name Cresco Labs gives it, and years follow its fiscal calendar.
Cresco Labs' revenue by segment goes back to fiscal 2024, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.